ANALYTICAL P MODULE 03738965001

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a * report with the FDA on 2010-09-14 for ANALYTICAL P MODULE 03738965001 manufactured by Roche Diagnostics.

Event Text Entries

[1709687] The user received questionable results for phenytoin on the analytical p module on two samples collected from the same patient. The initial result for phenytoin was 0. 0 ug/ml. The sample was automatically repeated by the analyzer which gave a result of 0. 0 ug/ml. Both the initial and repeat results were accompanied by data flags. The user said per their lab policy, if a phenytoin result is < 0. 6 ug/ml, then they will report out a result of < 0. 6 ug/ml. The user reported outside the laboratory a phenytoin result of < 0. 6 ug/ml for this patient sample. The user sent an aliquot of the original patient sample to another facility for repeat analysis which yielded a phenytoin result of 25. 8 ug/ml. The method or analyzer used for repeat testing was not provided. A second sample was collected from the patient on (b)(6) 2010 which gave an initial phenytoin result of 0. 0 ng/ml. The sample was automatically repeated by the p module giving 0. 0 ng/ml. Both the initial and repeat results were accompanied by data flags. The user reported outside the laboratory a phenytoin result of < 0. 6 ug/ml for this patient sample. The user sent an aliquot of the second sample to another facility for repeat analysis on an integra analyzer. The repeat phenytoin result was 33. 1 ug/ml. No adverse event has been alleged regarding these discrepancies. The user declined a field service dispatch. User said they believed this incident to be patient sample related. The phenytoin reagent lot number was 14829200. User said patient samples are available for further investigation.
Patient Sequence No: 1, Text Type: D, B5


[8782831] .
Patient Sequence No: 1, Text Type: N, H10


[17890584] .
Patient Sequence No: 1, Text Type: D, B5


[17912033] Data provided indiciated all control levels recovered acceptably. On the basis of the control recovery and investigation of the returned samples it can be concluded that the online phenytoin application is performing acceptably on the modular p analyzer. The extremely low phenytoin recoveries for the patient draws (below 0 ug/ml) are due to non-specific agglutination produced by some unknown component present in the patient sample. This interference is documented in product labeling. No adverse events in relation to the falsely low phenytoin result were reported.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1823260-2010-05430
MDR Report Key1833996
Report Source*
Date Received2010-09-14
Date of Report2010-12-06
Date of Event2010-08-18
Date Mfgr Received2010-08-26
Date Added to Maude2010-12-06
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location3
Manufacturer ContactERIC KOLODZIEJ
Manufacturer Street9115 HAGUE ROAD
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175212834
Manufacturer G1HITACHI HIGH TECH CORP.
Manufacturer Street882 ICHIGE HITACHINAKA
Manufacturer CityIBARAKI 312-8504
Manufacturer Postal Code312-8504
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameANALYTICAL P MODULE
Generic NameCLINICAL CHEMISTRY ANALYZER
Product CodeDKH
Date Received2010-09-14
Catalog Number03738965001
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD INDIANAPOLIS IN 46250 US 46250


Patients

Patient NumberTreatmentOutcomeDate
10 2010-09-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.